Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Metabolic » Lipodystrophy
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders » Lipodystrophy
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Skin Diseases, Metabolic » Lipodystrophy
Description
A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. MeSH
Hierarchy View
Subtype Terms (3)
HIV-Associated Lipodystrophy Syndrome
31 drugs (28 approved, 3 experimental)
Lipodystrophy, Congenital Generalized
3 drugs (1 approved, 2 experimental)
Lipodystrophy, Familial Partial
7 drugs (3 approved, 4 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (16)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (5)
Phase 1 Indicated Drugs (4)
Organization Involved with Phase 4 Indications (32)
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
French National Agency for Research on AIDS and Viral Hepatitis
Garvan Institute of Medical Research
Gottfried Wilhelm Leibniz Universität Hannover
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (8)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
